Renal Cell Carcinoma (RCC) Clinical Trials

Find Renal Cell Carcinoma (RCC) Clinical Trials Near You

Artificial Intelligence-Driven 3D Kidney Model for Real-Time Augmented Reality and Surgical Navigation in Minimally Invasive (Robotic/Laparoscopic) Partial Nephrectomy: A Prospective Validation Study

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study is to develop a real-time artificial intelligence-driven 3D kidney model to assist robotic or laparoscopic partial nephrectomy: • Can this AI-powered model optimize the workflow of partial nephrectomy and enhance surgical benefits?

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Ages 18-80 years, regardless of gender

• Written informed consent obtained from the patient or legally authorized representative after full protocol disclosure

• Preoperative imaging (CT/MRI) confirming clinical stage T1a or select T1b renal tumors suitable for partial nephrectomy (R.E.N.A.L. nephrometry score ≤10)

• Localized renal tumors without lymph node/distant metastasis per NCCN Guidelines® (v2023)

• Elective minimally invasive partial nephrectomy (laparoscopic/robotic) after comprehensive surgical counseling

Locations
Other Locations
China
The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)
RECRUITING
Nanjing
The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)
NOT_YET_RECRUITING
Nanjing
Contact Information
Primary
Pengfei Shao, Professor
spf032@hotmail.com
+8613851925825
Backup
Haoqi Miao, Postgraduate
mhq@stu.njmu.edu.cn
+8613276636957
Time Frame
Start Date: 2025-05-01
Estimated Completion Date: 2027-03-01
Participants
Target number of participants: 232
Treatments
No_intervention: Conventional Surgical Approaches
perform conventional laparoscopic or robotic-assisted surgical approaches
Experimental: AI model group
Use the AI-model to locate kidney and tumour, assisting surgeon with the operation
Related Therapeutic Areas
Sponsors
Leads: Shao Pengfei
Collaborators: Southeast University, China

This content was sourced from clinicaltrials.gov